Brellium is a forward-thinking company dedicated to enhancing the standard of care within the U.S. healthcare system through innovative AI-powered technology. Founded in 2021, Brellium has developed the first real-time medical review platform designed to identify and address clinical and compliance risks before they affect patients. With a mission to empower healthcare providers to deliver safer, higher-quality care, Brellium serves over 250,000 providers across all 50 states. As a Series A company backed by significant funding, Brellium is committed to providing tools that enable data-driven, compliant care at scale, while fostering a culture of collaboration, accountability, and customer obsession.